Khitahept (Tablets) Instructions for Use
Marketing Authorization Holder
Obnovlenie Pfc, JSC (Russia)
ATC Code
A05AX (Other drugs for the treatment of biliary tract diseases)
Active Substance
Cynara (BAN)
Dosage Form
| Khitahept | Film-coated tablets, 200 mg |
Dosage Form, Packaging, and Composition
Film-coated tablets
| 1 tab. | |
| Dry extract of Cynara scolymus (artichoke) leaves* (8-10):1 | 200 mg** |
* equivalent to 1.6-2 g of Cynara scolymus (artichoke) leaves.
** corresponding to a chlorogenic acid content of 0.5 mg-5 mg.
Extraction solvent water.
10 pcs. – blister packs (12 pcs.) – cardboard packs (120 pcs.) – Over-the-counter
10 pcs. – blister packs (18 pcs.) – cardboard packs (180 pcs.) – Over-the-counter
10 pcs. – blister packs (3 pcs.) – cardboard packs (30 pcs.) – Over-the-counter
10 pcs. – blister packs (6 pcs.) – cardboard packs (60 pcs.) – Over-the-counter
10 pcs. – blister packs (9 pcs.) – cardboard packs (90 pcs.) – Over-the-counter
120 pcs. – jars – cardboard packs (120 pcs.) – Over-the-counter
15 pcs. – blister packs (12 pcs.) – cardboard packs (180 pcs.) – Over-the-counter
15 pcs. – blister packs (2 pcs.) – cardboard packs (30 pcs.) – Over-the-counter
15 pcs. – blister packs (4 pcs.) – cardboard packs (60 pcs.) – Over-the-counter
15 pcs. – blister packs (6 pcs.) – cardboard packs (90 pcs.) – Over-the-counter
15 pcs. – blister packs (8 pcs.) – cardboard packs (120 pcs.) – Over-the-counter
180 pcs. – jars – cardboard packs (180 pcs.) – Over-the-counter
20 pcs. – blister packs (3 pcs.) – cardboard packs (60 pcs.) – Over-the-counter
20 pcs. – blister packs (6 pcs.) – cardboard packs (120 pcs.) – Over-the-counter
20 pcs. – blister packs (9 pcs.) – cardboard packs (180 pcs.) – Over-the-counter
30 pcs. – blister packs – cardboard packs (30 pcs.) – Over-the-counter
30 pcs. – blister packs (2 pcs.) – cardboard packs (60 pcs.) – Over-the-counter
30 pcs. – blister packs (3 pcs.) – cardboard packs (90 pcs.) – Over-the-counter
30 pcs. – blister packs (4 pcs.) – cardboard packs (120 pcs.) – Over-the-counter
30 pcs. – blister packs (6 pcs.) – cardboard packs (180 pcs.) – Over-the-counter
90 pcs. – jars – cardboard packs (90 pcs.) – Over-the-counter
Clinical-Pharmacological Group
Herbal preparation with choleretic and diuretic effect
Pharmacotherapeutic Group
Means for the treatment of diseases of the liver and biliary tract; agents for the treatment of diseases of the biliary tract; other agents for the treatment of diseases of the biliary tract
Pharmacological Action
A herbal preparation. The phenolic compound cynarin, in combination with phenolic acids (caffeic, chlorogenic, neochlorogenic, cryptochlorogenic), exerts a choleretic and hepatoprotective effect.
It increases the excretion of urea, toxins (including nitro compounds, alkaloids), and heavy metal salts from the body. It helps to reduce the cholesterol content in the blood.
The ascorbic acid, carotene, vitamins B1 and B2, rutin, and inulin contained in artichoke contribute to the normalization of metabolic processes.
Indications
As an adjunctive agent for biliary dyskinesia of the hypokinetic type, cholecystitis, chronic hepatitis, anorexia, chronic intoxications (with hepatotoxic substances, nitro compounds, alkaloids, heavy metal salts), chronic renal failure, urolithiasis, uraturia, atherosclerosis, obesity.
ICD codes
| ICD-10 code | Indication |
| B18 | Chronic viral hepatitis |
| E66 | Obesity |
| I70 | Atherosclerosis |
| K71 | Toxic liver disease |
| K73 | Chronic hepatitis, not elsewhere classified |
| K81.1 | Chronic cholecystitis |
| K82.8 | Other specified diseases of gallbladder and cystic duct (including dyskinesia) |
| N18 | Chronic kidney disease |
| N20 | Calculus of kidney and ureter |
| N21 | Calculus of lower urinary tract |
| R63.0 | Anorexia |
| T56 | Toxic effect of metals |
| T65.8 | Other specified substances |
| ICD-11 code | Indication |
| 1E51.Z | Chronic viral hepatitis, unspecified |
| 4A85.00 | Drug hypersensitivity-induced liver disease |
| 5B81.Z | Obesity, unspecified |
| BD40.Z | Atherosclerosis of peripheral arteries, unspecified |
| DB95.Z | Drug-induced or toxic liver disease, unspecified |
| DB97.2 | Chronic hepatitis, not elsewhere classified |
| DC12.1 | Chronic cholecystitis |
| DC1Z | Diseases of gallbladder and biliary tract, unspecified |
| DD94 | Functional disorder of the gallbladder |
| GB61.Z | Chronic kidney disease, unspecified stage |
| GB70.Z | Calculus of upper urinary tract, unspecified |
| GB71.Z | Calculus of lower urinary tract, unspecified |
| MG43.7 | Anorexia |
| NE61 | Toxic effect of poisonous substances, chiefly nonmedicinal, not elsewhere classified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer the tablets orally. Swallow whole with a sufficient amount of liquid. Do not chew.
The standard adult dosage is one tablet (200 mg) taken three to four times daily. Adhere to this regimen unless otherwise directed by a physician.
Take the tablets before meals. This timing supports the physiological process of digestion and enhances the choleretic effect.
The duration of treatment is determined by the treating physician based on the underlying condition and clinical response. For chronic conditions, long-term use may be necessary.
For specific indications, adjust the regimen as follows: for biliary dyskinesia and chronic cholecystitis, use as part of a comprehensive therapeutic plan; for chronic intoxications, utilize the standard dosage to support detoxification processes.
Do not exceed the recommended daily dose. In case of a missed dose, take it as soon as remembered if it is not almost time for the next dose. Do not double the dose to catch up.
Discontinue use and consult a physician immediately if severe adverse reactions occur or if symptoms of the underlying condition worsen.
Adverse Reactions
Allergic reactions skin manifestations.
From the digestive system with prolonged use in high doses – diarrhea.
Contraindications
Acute diseases of the liver, biliary tract, kidneys, urinary tract, gastrointestinal tract; large stones in the biliary and urinary tracts; biliary dyskinesia of the hyperkinetic type; hypersensitivity to artichoke.
Use in Pregnancy and Lactation
Data on the safety of artichoke use during pregnancy and lactation are not available.
Use in Hepatic Impairment
Contraindicated in acute liver diseases.
Use in Renal Impairment
Contraindicated in acute kidney diseases.
Pediatric Use
Use in dosage forms intended for this category of patients.
Special Precautions
At the beginning of treatment, in some cases, an increase in blood cholesterol levels is possible, then this indicator normalizes and even decreases.
In children, use in dosage forms intended for this category of patients.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Noopept, pills 10mg, 50pcs
No-spa pills 40mg, 64pcs
Daivobet, ointment, 30g
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Arbidol, capsules 100mg, 40pcs
Picamilon pills 50mg, 60pcs
Kagocel pills 12mg, 30pcs
Mildronate capsules 500mg, 90pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Belosalic, lotion solution for external use spray 100ml
Fenotropil pills 100mg, 60pcs
Ingavirin capsules 90mg, 10pcs
Cortexin, 10mg, 5ml, 10pcs
Actovegin pills 200mg, 50pcs
Phenibut-Vertex pills 250mg, 20pcs
Belosalic, ointment, 30g 